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Simple Summary: Halophilic archaea are microorganisms that inhabit in extreme environments
for life, under salt saturation, high temperature and elevated UV radiation. The interest in these
microorganisms lies on the properties of their molecules, that present high salt and temperature
tolerance, as well as, antioxidant power, being an excellent source of compounds for several
biotechnological applications. However, the bioactive properties from haloarcahaea remain scarcely
studied compared to other groups as plants or algae, usually reported as good health promoters.
In this work we describe the isolation and the molecular identification of two new haloarchaeal strains
from Odiel salterns (SW Spain), and the antioxidant, antimicrobial and bioactive potential of their
extracts. The results revealed that the extracts obtained with acetone presented the highest activities
in the antioxidant, antimicrobial and anti-inflammatory assays, becoming a promising source of
metabolites with applied interest in pharmacy, cosmetics and food industry.
Abstract: The need to survive in extreme environments has furnished haloarchaea with a series
of components specially adapted to work in such conditions. The possible application of these
molecules in the pharmaceutical and industrial fields has received increasing attention; however,
many potential bioactivities of haloarchaea are still poorly explored. In this paper, we describe the
isolation and identification of two new haloarchaeal strains from the saltern ponds located in the
marshlands of the Odiel River, in the southwest of Spain, as well as the in vitro assessment of their
antioxidant, antimicrobial, and bioactive properties. The acetone extract obtained from the new
isolated Haloarcula strain exhibited the highest antioxidant activity, while the acetone extracts from
both isolated strains demonstrated a strong antimicrobial activity, especially against other halophilic
microorganisms. Moreover, these extracts showed a remarkable ability to inhibit the enzyme
cyclooxygenase-2 and to activate the melanogenic enzyme tyrosinase, indicating their potential
against chronic inflammation and skin pigmentation disorders. Finally, the aqueous protein-rich
extracts obtained from both haloarchaea exhibited an important inhibitory effect on the activity of the
acetylcholinesterase enzyme, involved in the hydrolysis of cholinergic neurotransmitters and related
to several neurological diseases.
Keywords: antioxidant; anti-inflammatory; antimicrobial; bioactive substances; haloarchaea
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1. Introduction
Halophilic archaea or haloarchaea are a group of extremophilic microorganisms inhabiting
hypersaline environments, such as salt lakes and salterns. They thrive in harsh conditions
for life, including low water availability, high salt concentration, and elevated solar irradiance,
which implies high temperature and ultra-violet (UV) radiation [1,2]. The biotechnological interest in
the haloarchaeal group has increased due to their ability to produce a wide variety of compounds such
as exopolysaccharides, carotenoids, and proteins adapted to work in such extreme conditions. The
tolerance of these enzymes to elevated saline concentrations and temperatures, the high antioxidant
power and therapeutic potential of haloarchaeal carotenoids or the good jellifying properties and
thermal stability of the exopolysacharides secreted by many archaea make these metabolites highly
appreciated for numerous biotechnological applications, including biomedical, pharmaceutical,
cosmetic, environmental or industrial purposes [3,4]. Furthermore, considering that only a small
part of the existing archaeal species has been discovered and studied, it is expected that many
other metabolites with unexplored bioactivities can be obtained from this extraordinary group of
microorganisms, as pointed in recent reviews [5].
Haloarchaea have shown to be particularly suitable for the production of extremozymes, which can
tolerate high temperatures and saturating salt concentrations, conditions required in food, detergent
and textile sectors [6,7]. In addition, a common feature within the haloarchaeal group is their ability to
secrete halocins, which are peptides or proteins able to inhibit the growth of susceptible microorganisms
living in the same habitat [8,9]. These molecules are also resistant to extreme conditions and could be a
source of new antimicrobial compounds. Moreover, most haloarchaea can produce and accumulate
carotenoids, which are responsible for their red color. Carotenoids are antioxidant compounds with an
important role as human health enhancers, and it is widely known that their regular consumption helps
to prevent many degenerative diseases, such as neurodegeneration, cancer, cardiovascular diseases,
macular degeneration and cataracts [10,11].
Carotenoids from haloarchaea have shown anticancer and antihemolytic activities [12], and the
ability to increase sperm cells viability after cryopreservation [13]. Furthermore, many natural
carotenoids are used as food preservatives and pharmaceutical and cosmetic compounds due
to their antioxidant and pro-vitamin properties [14]. Bacterioruberin (BR) and its derivatives,
monoanhydrobacterioruberin (MABR) and bisanhydrobacterioruberin (BABR), are the main carotenoids
synthesized by halophilic archaea [15–17]. These carotenoids have 50 carbon atoms (C50) and possess a
longer system of conjugated double bonds than the C40 carotenoids usually found in other organisms
such as plants, microalgae, fungi and bacteria [14]. Some C40 carotenoids, such as phytoene, lycopene
and β-carotene have also been found in haloarchaea, but at such low quantities that they have been
proposed as metabolic intermediates for the biosynthesis of C50 carotenoids [18,19]. Even though
carotenoids play a unique important role in cell protection against oxidative damage, bacterioruberin
appears also to be a stabilizer of the cell membrane under osmotic stress [20]. Because of the structure
of bacterioruberin, it can be inferred that its antioxidant potential might be even higher than that
of β-carotene, due to the fact that it has 13 conjugated double bonds and four hydroxyl groups,
compared to the 9 conjugated double bonds and none hydroxyl group of β-carotene [16]. For those
reasons, the antioxidant power of haloarchaeal extracts and their potential as alternative to current
food preservatives and as drug leads should be more deeply studied.
Pigments from different kinds of marine microorganisms have shown effective antibacterial
properties. Examples of this are the red pigment prodigiosin, isolated from the sponge-associated
bacterium Serratia marcescens [21]; or the chlorophyll a derivatives obtained from the microalga
Isochrysis galbana [22]. Recently, the antimicrobial activity of pigments from some halophilic bacteria
has been tested against bacteria and fungi [23]; however, so far, the studies about the antimicrobial
activity of haloarchaeal pigments or extracts thereof are scarce [19,24].
The main aim of this work is to explore the bioactive properties of different extracts obtained from
two new strains of haloarchaea isolated from the Odiel solar saltern (SW Spain), focusing on their
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antioxidant and antimicrobial activities; and their capability to modulate the activity of disease-related
enzymes involved in melanin biosynthesis, neurological degeneration, carbohydrate metabolism,
and inflammatory response, through in vitro assays.
2. Materials and Methods
2.1. Sample Collection
Water samples were collected from a crystallizer pond located in the natural reserve of the Odiel
Marshlands, in the southwest of Spain (Latitude: 37.2395, longitude: −6.95287). The ionic composition
and the physicochemical parameters of the water brine were determined by the standard methods,
as previously reported [20].
2.2. Archaea Isolation
The biomass from 2 L of the collected water samples was harvested by centrifugation at 19,800× g,
resuspended in 20 mL of archaeal medium (ATCC 1176 medium) and used for the isolation of archaeal
colonies on agar plates. Typically, 1 mL of serial dilution corresponding to 1:10, 1:100 and 1:1000 were
spread on agar medium containing 20% of salt. After incubation at 37 ◦C for 15 days, red and pink
colonies were visible. Selected colonies were purified by at least three streaking rounds on fresh agar
plates. The isolates were preserved in 20% glycerol (w/v) at −80 ◦C for further use.
2.3. Preliminary Selection of Archaeal Strains with Antimicrobial Activity
Halocin activity was determined by observing growth inhibition of the archaea Haloferax lucetense
(CECT 5871), which was purchased from CECT (Spanish Collection of Culture Type, Valencia, Spain)
and whose susceptibility to the halocin activity of the species inhabiting Odiel salterns was previously
probed [25]. H. lucetense was grown on the medium specified by the CECT (MHE 25 Medium;
CECT 188), and 1 mL of the culture was completely spread across the surface of a Petri dish. When the
plate was totally dried, a 20 µL drop of the culture of each previously isolated colony was spotlessly
placed onto the Petri dish. The inhibition of H. lucetense growth was measured by the formation of a
clearance zone around each drop added.
2.4. Identification of the Selected Microorganisms
Genomic DNA of each strain was extracted using the GeneJET Genomic Purification
kit (Thermo Fisher Scientific, Waltham, MA, USA), following the manufacturer’s instructions.
Quantification of the genomic DNA obtained, and the assessment of its purity was done on a Nanodrop
Spectrophotometer ND-1000 (Thermo Fisher Scientific). The full length of the 16S rRNA encoding
gene was amplified with the archaeal specific primers 21F (5′-TTCCGGTTGATCCTGCCGGA-3′) and
1492R (5′-GGTTACCTTGTTACGACTT-3′). Polymerase chain reactions (PCR) were performed in a
total volume of 25 µL containing: 1 µL of genomic DNA, 10 pM of each primer, 0.2 mM dNTPs, 0.2 U
REDTaq®DNA polymerase from Sigma Aldrich (St. Louis, Missouri, USA) 2.5 µL of specific 10X
buffer and 1.5 µL of 2.5 mM MgCl2 buffer using an Eppendorf thermo-cycler. The thermal profile
corresponded to 0.5 min at 96 ◦C, 0.5 min at 55 ◦C and 1 min at 72 ◦C for 30 cycles, followed by 10 min
of final primer extension. The PCR products were analyzed by electrophoresis on a 1 % agarose gel
to check their quality and sent to Stabvida (Lisbon, Portugal) for Sanger sequencing. The 1.4 kb 16S
rRNA gene sequences obtained were compared to those available at the GenBank and the European
Molecular Biology Laboratory (EMBL) databases using advanced Basic Local Alignment Search Tool
(BLAST), Megablast and BLASTn, searches at the National Center for Biotechnology Information
(NCBI) [26].
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2.5. Archaeal Culture Conditions
The medium used for haloarchaeal growth contained (per liter): 10 g glucose, 156 g NaCl, 13 g
MgCl2·6H2O, 20 g MgSO4·7H2O, 1 g CaCl2·6H2O, 4 g KCl, 0.2 g NaHCO3, 0.5 g NaBr and 5 g yeast
extract. The pH was adjusted to 7 before autoclaving. The cultures were incubated in Erlenmeyer
flasks at 37 ◦C at 100 rpm for one week.
2.6. Preparation of Archaeal Extracts
When cultures reached the stationary phase of growth, 1 L of each culture was collected by
centrifugation at 19,800× g for 30 min at 4 ◦C. The obtained cellular pellets were subjected to five
freezing-unfreezing cycles, by successive 1 min immersions in liquid nitrogen/hot water (60 ◦C).
The obtained cell lysates were treated overnight with 100 mL of cold acetone (−20 ◦C) in the dark. Then,
acetone extracts were centrifuged at 4 ◦C and 19,800× g for 30 min. The resulting pellet, containing the
proteins precipitated with cold acetone and the acetone supernatant, containing carotenoids and other
lipophilic compounds, were dried in a rotary vacuum evaporator and freeze-dried for further study.
The total content of carotenoids in acetone extracts was determined by measuring the absorbance of
the sample at 494 nm in a cuvette with a 1 cm path length and using the specific absorption coefficient
E11% = 2500 (100 mL g−1 cm−1) according to Hiyana et al. [27]. Similarly, the concentration of proteins
in the acetone precipitated extracts, hereinafter called aqueous extract, was determined by Bradford’s
method [28].
Potential bioactive compounds excreted into the culture medium by the selected archaea were
recovered from 500 mL of each culture medium by successive liquid/liquid extractions with 50 mL
of four organic solvents in this order: hexane, dichloromethane, ethyl acetate, and chloroform.
The extraction with each solvent was repeated three times. All the fractions were evaporated to dryness
in a rotary evaporator under reduced pressure at 50 ◦C, freeze-dried, and stored until further use.
2.7. Antioxidant Activity Assays
Different assays were conducted to test the antioxidant activity of archaea cell extracts and all the
extracellular extracts obtained from the culture medium, as previously described. Each freeze-dried
extract was homogenized and dissolved in DMSO (at 10 mg mL−1) except for the acetone precipitate,
which was resuspended in phosphate-buffered saline (PBS) buffer. All samples were tested at a
concentration of 1 mg mL−1. Butylated hydroxytoluene (BHT, 1 mg mL−1) was used as positive control
in the 1,1-Diphenyl-2-picrylhydrazyl (DPPH), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid
(ABTS) and nitric oxide (NO) radical scavenging assays, and in the ferrocyanide reduction potential
(FRP), while the metal chelator EDTA (1 mg mL−1) was employed as positive control in the copper
(CCA) and iron (ICA) chelating assays. The solvent employed to dissolve the extracts (DMSO or PBS)
was used as negative control. All the measurements were carried out at least six times on 96-well
plates. The radical scavenging activity was expressed as percent of inhibition relative to the negative
control, following the formula:
% Scavenging activity = 100− Abs sample× 100
Abs negative control
When the activity of a sample was higher than 65%, the concentration of the extract providing
50% reduction of the radical scavenging activity (IC50 or EC50) was calculated by sigmoidal fitting of
the data, using the GraphPad Prism 6 program. These values were calculated from a graph built by
plotting the log of the radical scavenging activity (%) against the normalized sample concentration,
according to the concentration of proteins or carotenoids in the extracts.
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2.7.1. DPPH Assay
1,1-Diphenyl-2-picrylhydrazyl radical scavenging assay was performed by the method of
Sachindra et al. [29] with some modifications. A solution of DPPH 0.12 mM was prepared in methanol;
200 µL of this DPPH solution were mixed with 22 µL of each extract solution. The absorbance decrease
at 517 nm was recorded in a microplate reader, after incubation at 25 ◦C for 30 min in the dark. A color
control prepared with 200 µL of methanol and 22 µL of each extract sample was included in all
the assays.
2.7.2. ABTS Assay
Free radical scavenging activity of the extracts was determined by the ABTS+ (2,2′-azino-bis
(3-ethylbenzothiazoline-6-sulfonic acid)) radical cation decolorization assay [30]. ABTS+ cation radical
was generated by the reaction between ABTS (7 mM in water) and potassium persulfate (2.5 mM),
in the dark at room temperature for 12–16 h. The ABTS+ solution was then diluted with methanol
to obtain an absorbance of 0.700 at 734 nm. After the addition of 10 µL of each extract to 190 µL of
the diluted ABTS+ solution, the samples were incubated for 6 min in the dark and the absorbance at
734 nm was measured after the incubation.
2.7.3. Nitric Oxide (NO) Assay
The capacity to scavenge the free radical NO was evaluated according to Baliga et al. [31]. Briefly,
50 µL of extracts were mixed with 50 µL of sodium nitroprusside (10 mM in PBS) and incubated for
90 min at room temperature before adding 50 µL of Griess reagent. After that, the absorbance was
measured at 546 nm.
2.7.4. Ferrocyanide Reducing Power (FRP) Assay
The reducing power assay was performed according to Tundis et al. [32]. The assay solution
was prepared by mixing 50 µL of sample solution, 50 µL of distilled water and 50 µL of potassium
ferrocyanide (1%). After 20 min of incubation, 50 µL of TCA (10%) and 10 µL of FeCl3 (0.1%) were
added and the mix was incubated 10 min before measuring the absorbance at 700 nm.
2.7.5. Metal Chelating Activity on Iron and Copper Ions
Both assays were conducted according to Megías et al. [33]. Iron chelating activity (ICA) was
determined by measuring the formation of the Fe2+-ferrozine, by measuring the absorbance at 562 nm.
Copper chelating activity (CCA) was determined using pyrocatechol violet (PV), detecting the color
change at 632 nm.
2.8. Inhibition of Carbohydrate-Hydrolyzing Enzymes
The ability of the obtained extracts to inhibit the carbohydrate-hydrolyzing enzymes α-amylase
and α-glucosidase was tested by incubating dilutions of the haloarchaeal extracts (1 mg mL−1), prepared
in sodium phosphate buffer 0.1 M pH 7, with the corresponding enzymes. Acarbose (1 mg mL−1) was
used as positive control and the buffer was employed as negative control. A blank, made with the
buffer without the corresponding assayed enzyme, was also included. All the assays were conducted
in 96 well plates and repeated at least six times. The inhibitory activity was calculated according to
the formula:
% Inhibitory activity = 100 × Abs sample−Abs blank
Abs negative control
2.8.1. α-Amylase Inhibition Test
The α-amylase inhibition assay was performed as previously described by Iauk et al. [34]. Briefly,
40 µL of sample were mixed with 40 µL of amylase solution (100 U mL−1 in buffer) and 40 µL of starch
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solution (0.1% in buffer sodium phosphate buffer 0.1M pH 7) and incubated 10 min at 37 ◦C. After that,
20 µL of HCl (1 M) and 100 µL of iodide solution (5 mM I2 + 5 mM KI, in dH2O) were added and the
absorbance at 580 nm was read.
2.8.2. α-Glucosidase Inhibition Test
The α-glucosidase inhibition assay was performed according to Iauk et al. [34]. Concisely, 50 µL
of sample were added to 100 µL of enzyme solution (1.0 U mL−1) and incubated 10 min at room
temperature. Then, 50 µL of 5mM p-nitrophenyl-a-D glucopyranoside was added and, after another
incubation of 5 min at 25 ◦C, the absorbance was read at 405 nm.
2.9. Acetylcholinesterase (AChE) Activity
The AChE activity was measured by the Ellman method as described by Orhan et al. [35].
Typically, 20 µL of each sample (10 mg mL−1 in DMSO) were mixed with 140 µL of 0.1 mM sodium
phosphate buffer (pH 8.0) and 20 µL of an AChE (EC.3.1.1.7) solution (0.28 U mL−1) from electric eel,
and incubated at room temperature for 15 min. The reaction was started by adding 10 µL of ATChI
(acetylthiocholine iodide, 4 mg mL−1) together with 20 µL of DTNB (5,5-dithiobis-2-nitrobenzoic acid,
1.2 mg mL−1). The hydrolysis of ATChI was monitored at 412 nm, by the formation of the yellow
5-thio-2-nitrobenzoate anion as a result of the reaction between DTNB and the thiocholine produced
from the reaction catalyzed by the enzyme. Results were expressed as percentages of activity relative
to the negative control, as indicated above. Galantamine (1 mg mL−1) was used as positive inhibitory
control, while the sample solvent was set as the negative control. All the reactions were carried out in
96-well microplates and repeated at least six times.
2.10. Tyrosinase (TYRO) Activity
The effect of the different extracts on the tyrosinase activity was determined, by the method
reported by Nerya et al. [36] with some modifications. Essentially, 70 µL of samples (10 mg mL−1)
dissolved in phosphate buffer 25 mM pH 6.5 were mixed with 30 µL of TYRO (333 U mL-1 in phosphate
buffer, pH 6.5) and incubated for 5 min. After that, 110 µL of substrate (L-tyrosine, 2 mM in water)
were added and further incubated for 30 min at room temperature, before reading the optical densities
at 492 nm. The assays were done with six replicates for each sample in 96 well plates and arbutin
(1 mg mL−1) was used as positive control. Results were expressed as percentage of activity relative to
a negative control as previously detailed, containing the buffer in place of the sample.
2.11. Cyclooxygenase 2 (COX-2) Activity
The anti-inflammatory activity of the extracts was studied by testing the inhibition of the enzyme
cyclooxygenase 2 (COX-2), using the fluorometric COX-2 Inhibitor Screening Kit, Biovision K547-100
(Life Science, Milpitas, CA, USA). This assay is based on the fluorometric detection of Prostaglandin
G2, the intermediate product generated by the COX enzyme from arachidonic acid. All the extracts
were tested at a concentration of 1 mg mL−1 and solved in PBS, except the acetone ones, which were
prepared in acetone to obtain a better solubility. All the assays were conducted in triplicate, following
the manufacturer’s indications. The reactions were started by adding 10 µL of the provided arachidonic
acid, using 10 µL of the samples in a final volume of 100 µL of reaction mixture. Celecoxib (2 mM)
was employed as positive control and the corresponding solvents, PBS and acetone, were used as
negative control of COX-2 inhibition. The fluorometric detection (Ex/Em = 535/587 nm) was recorded
in a fluorimeter FLUOstar Omega, BMG LABTECH, and the percentage of inhibition was calculated
from the slope for all samples, including Enzyme Control (EC) as follows:
% Relative Inhibition =
Slope o f EC− Slope o f Sample
Slope o f EC
× 100
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2.12. Antimicrobial Activity
2.12.1. Strains and Media
The antimicrobial activity of the extracts obtained from the two selected haloarchaea strains
was tested against different kinds of microorganisms including bacteria, microalgae, yeast, and
archaea. The bacteria included in the assays were fish pathogens, kindly provided by the Andalusian
Institute of Agriculture research: Streptococcus parauberis DSM 6631T, Lactococcus garvieae CECT 4531T,
Tenacibaculum maritimum CECT 4276, Tenacibaculum soleae CECT 7292T, Pseudomonas anguilliseptica
CECT 899T, Pseudomonas moraviensis DSM 16007T, Pseudomonas plecoglossicida DSM 15088T, Edwardsiella
tarda CECT 849T, Edwardsiella tarda CECT 849T, Vibrio anguillarum CECT 522T, Vibrio harveyi CECT 525T,
Vibrio tapetis CECT 4600T, Aeromonas salmonicida salmonicida CECT 894T, Pseudomonas baetica a390T,
Mycobacterium marinum CECT 7091T, Yersinia ruckeri CECT 4319T, Photobacterium damsela damselae
CECT 626T; common human pathogenic bacteria: Micrococcus luteus CECT 245, Bacillus cereus CECT
40 and Staphylococcus aureus, provided by the Microbiology and Parasitology Department of the
University of Seville and the Gram negative Escherichia coli DH5α, related to human pathogenic strains.
Among the microalgae, two freshwater species, Chlorella sorokiniana and Chlamydomonas reinhardtii
21gr, and two hypersaline species, Dunaliella salina and Dunaliella bardawil were tested. Antifungal
activity was assayed against three different yeasts; Saccharomyces cerevisiae F13A, Rhodotorula sp.,
and Rhodospirillum toruloides 1854, supplied by the University of Algarve. Finally, the inhibitory
activity of the obtained extracts against different haloarchaeal genera was studied in: Haloferax CECT
5871, Halogeometricum, Halogiper, Halorubrum, Haloterrigena, and Natrinema, generously given by the
University of Mentouri’s Bothers in Constantine, Algeria. All the tested species are listed in Table 1,
in the Results section.
Table 1. Antimicrobial activity of acetone extracts.
Target Microorganisms
Acetone Extract
H. hispanica
HM1
H. salinarum
HM2
Human
pathogenic
bacteria
Bacillus cereus + +
Escherichia coli + −
Micrococcus luteus + ++
Staphylococcus aureus + +
Marine fish
pathogenic
bacteria
Aeromonas salmonicida CECT 894T − −
Edwardsiella tarda CECT 849T − −
Lactococcus garvieae CECT 4531T − −
Nocardia seriolae DSM 44129T − −
Photobacterium damsela damselae CECT 626T + ++
Pseudomonas anguilliseptica CECT 899T ++ ++
Pseudomonas baetica A390T − −
Pseudomonas moraviensis DSM 16007T − −
Pseudomonas plecoglossicida DSM 15088T − −
Streptococcus iniae CECT 7363T − −
Streptococcus parauberis DSM 6631T − +
Tenacibaculum soleae CECT 7292T + −
Vibrio aestuarianus CECT 625T − −
Vibrio anguillarum CECT 522T + +
Vibrio harveyi CECT 525T ++ ++
Vibrio tapetis CECT 4600T + ++
Yersinia ruckeri CECT 4319T + +
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Table 1. Cont.
Target Microorganisms
Acetone Extract
H. hispanica
HM1
H. salinarum
HM2
Halophilic archaea
and bacteria
Haloferax lucentense + ++
Haloferax mediterranei +++ +++
Halogeometricum +++ +++
Halogiper ++ ++
Halorubrum ++ +++
Haloterrigena ++ ++
Natrinema + +
Salinibacter ruber +++ +++
Microalgae
Chlamydomonas reinhardtii 21GR + ++
Chlorella sorokiniana + ++
Dunaliella bardawil +++ ++++
Dunaliella salina +++ ++++
Yeasts
Rhodospirillum toruloides 1854 − −
Rhodotorula sp. − −
Saccharomyces cerevisiae F13A − −
Microbial susceptibility was tested by agar diffusion assays and expressed as a function of the diameter of the
growth inhibition zone: halo from 0.5 to 1 cm (+), halo from 1 to 2 cm (++), halo from 2 to 4 cm (+++) and halo from
4 to 6 cm (++++); absence of susceptibility (−). For a visual aspect of the halos, please refer to Figure 4.
Human pathogenic bacteria were cultured in LB (Luria–Bertani) medium, while fish pathogens
were cultured in TSB (Tryptic Soy Broth) medium. Fresh water microalgae were cultured in TAP
(Tris-Acetate-Phosphate) medium, whereas halophilic microalgae were cultured in modified Johnson’s
medium [37,38]. Finally, YPD (Yeast extract-Peptone-Dextrose) and MHE 25 (CECT 188) media were
used for yeast and archaea growth, respectively.
2.12.2. Agar Diffusion Method
The indicator strains were grown in liquid media until they reached the late exponential phase
of growth. Then, 1 mL inoculums of approximately 107 UFC mL−1 were spread across agar plates
with their appropriate growth media. Once cell suspensions were completely dried, a 10 µL drop
of each extract (10 mg DW mL−1) was added to the plate. The extracts obtained from the culture
media were resuspended in water or DMSO/water (1:4), while the precipitate and the supernatant
obtained by extraction with acetone were diluted in PBS and acetone/water (1:4), respectively. The
absence of toxicity of all the solvents was confirmed before the assays. The inhibition of growth was
checked after the corresponding incubation period; 24 h at 37 ◦C for human pathogenic bacteria; 24 h
at 25 ◦C for fish pathogenic bacteria; 48 h at 25 ◦C and light (100 µE m−2 s−1 of intensity) for fresh water
microalgae; 7 days at 25 ◦C and light (100 µE m−2 s−1 of intensity) for hypersaline water microalgae;
24 h at 30 ◦C for yeasts; and 7 days at 37 ◦C for haloarchaea. The antimicrobial activity was determined
measuring the size of the inhibition zone around the spotted drops. All the experiments were carried
out in triplicate.
2.12.3. MIC Determination
Several dilutions of the active extracts were assayed to determine their Minimal Inhibitory
Concentration (MIC) for the most susceptible microorganisms of each tested group using the agar
diffusion method, as previously described, to detect the lowest extract concentration able to inhibit the
growth of the selected microorganisms.
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2.13. Statistical Analysis
The results were expressed as the mean ± SD of at least triplicate experiments. The data were
submitted to one-way variance analysis (ANOVA) and the differences between means were evaluated by
a Duncan’s Multiple Range Test. The data were analyzed using the statistical and data analysis solution
for Microsoft Excel (XLSTAT 2020, New York, NY, USA). Differences were considered significant at
p < 0.05.
3. Results and Discussion
3.1. Isolation, Selection, and Identification of Haloarchaeal Strains
Two new haloarchaeal strains were isolated from environmental water samples, collected at the
end of the summer from a salt evaporation pond located in the natural reserve of Odiel Marshlands,
where rivers Tinto and Odiel flow into the Atlantic Ocean in the city of Huelva (SW Spain). The total
salinity of the water collected was 33.23 g L−1, being the composition of the brine of 1.40 g CaSO4,
23.06 g MgSO4, 34.08 g MgCl2, 265.38 g NaCl, 7.51 g KCl and 0.84 g NaBr per liter.
These strains were chosen among a series of haloarchaeal colonies initially isolated from the water
samples by serial dilution and successive streaking rounds on agar plates. Those which showed the
most vigorous growth and exhibited the highest halocin activity, preliminary tested against Haloferax
lucentense, were selected to further investigate their antimicrobial potential against a wide number of
pathogenic bacteria and other bioactivities, such antioxidant and anti-inflammatory activities as well
as their neuroprotective, melanogenic, or antidiabetic potential properties.
Amplification of the complete 16S rRNA sequence encoding gene from the new haloarchaeal
strains was performed using the primers 21F y 1492R and procedures described in the materials
and method section. Comparison of the obtained sequences (Supplementary Materials) with the
NCBI database using the BLASTn tool revealed that the two new strains isolated belong to the genus
Haloarcula and Halobacterium, respectively. The first isolate shared a 98.68% of sequence identity with
Haloarcula hispanica, consequently it was designated as Haloarcula hispanica HM1. The 16S rRNA gene
of the second haloarchaea isolated, on the other hand, showed high percentage of identity with the
corresponding sequence of Halobacterium salinarum (97.53%). In addition, a Molecular Phylogenetic
Analysis was conducted using the Molecular Evolutionary Genetics Analysis (MEGA) program version
7, including the sequences obtained and the complete sequences of a series of 16S rRNA coding genes
available in the NCBI database for several members of the corresponding genus (Figure 1). In both
cases, Haloferax volcanii was used as outgroup and the bootstrap was set at 1000 replicates. The 16S
rRNA encoding sequence of the first isolate forms a cluster with the corresponding genes of H. hispanica
and is closely related with the sequence of other Haloarcula species (Figure 1A). Otherwise, the 16S
rRNA sequence of the second haloarchaea isolated clusters together with H. salinarum sequences and
is highly related with the sequence of several species of the genus Halobacterium (Figure 1B).
Haloarcula [39,40] and Halobacterium [41,42] genera belong to the Halobacteriaceae family within
the Halobacteriales order. Currently, ten recognized species are included in the Haloarcula genus:
H. amylolytica [43], H. argentinensis [44], H. vallismortis [45], H. marismortui [46], H. hispanica [47],
H. japonica [48], H. quadrata [49], H. sinaiiensis [50], H. Salaria and H. Tradensis [51]; while to date,
five species comprise the Halobacterium genus: H. Jilantaiense [52], H. litoreum [53], H. noricense [54],
H. rubrum [55] and H. salinarum [56]. Several strains of these species have been described due to the
divergence of their 16S RNA coding gene sequences, as is the case of the two strains proposed here,
which have been designated as Haloarcula hispanica HM1 and Halobacterium salinarum HM2.
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Figure 1. Molecular Phylogenetic Analysis by Maximum Likelihood Method. The trees represent a
comparison among the 16S rRNA sequences from the new strains isolated, H. hispanica HM1 (A) and
H. salinaru HM2 (B), and a series of reference archaeal sequences. Multiple alignments were generated
by MUSCLE ( Ultiple Sequence Comparison by Log-Expectation) and the trees were constructed with
MEGA 7. The numbers at nodes indicate the bootstrap values calculated for 1000 replicates. The name
and the NCBI access number are indicated for all the reference sequences. Black triangles indicate the
new strains identified.
3.2. Bioactive Properties of the Extracts from H. Hispanica HM1 and H. Salinarum HM2
A total of 12 extracts, six from each of the new isolated haloarchaeal strains, were obtained from
cultures of H. hispanica HM1 and H. salinarum HM2 harvested at the end of the stationary phase of
growth. Hexane, dichloromethane, ethyl acetate, and chloroform extracellular extracts were recovered
from the culture media, while acetone and aqueous extracts were obtained from the archaea biomass.
The potential bioactive properties of all these extracts was tested as detailed below.
3.2.1. Antioxidant Capacity
The antioxidant potential of all the extracts was tested in radical scavenging assays, based on
DPPH, ABTS, or NO, by the ferrocyanide reduction potential (FRP), and ICA and CCA metal chelation
assays. The half maximal inhibitory concentration (IC50) or the half maximal effective concentration
(EC50) was calculated using the prism program version 6 for the extracts that exhibited antioxidant
activities higher than 65% (Figure 2).
None of the extracellular extracts obtained from the culture media was found to have antioxidant
activity, while cellular extracts showed a considerable antioxidant activity, being able to scavenge
DPPH, and ABTS radicals, reduce ferrocyanide and chelate copper, but not scavenge NO radicals or
chelate iron. The aqueous extracts obtained from H. hispanica HM1 and H. salinarum HM2 biomass
showed a moderate antioxidant capacity on DPPH, ABTS, and CCA assays, with inhibition values
between 20 and 30%, and an important ability to reduce ferrocyanide, with values around 70 and 80%.
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the haloarchaeal strains H. hispanica HM1 and H. salinarum HM2, determined by DPPH
(1,1-Diphenyl-2-picrylhydrazyl) and ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid))
radical scavenging assays, or FRP (Ferrous ion reduction potential) and CCA (Copper chelating
activity). For each assay, the data were submitted to one-way variance analysis (ANOVA). Bars are
followed by different superscript letters (a, b or c), which denote groups with significant differences
according to the Duncan’s Multiple Range Test (p < 0.05) (A). The half maximal inhibitory or effective
concentration (IC50 or EC50) were calculated when the activity was higher than 65% (B). These
values were normalized to the content of proteins and carotenoids in the extracts, being the protein
concentration of the aqueous extract 47 and 30 µg per mg DW and the carotenoid content of 10 and
12 µg per mg DW, respectively, for H. hispanica HM1 and H. salinarum HM2.
The acetone extracts obtained from H. hispanica HM1 presented high antioxidant activity when
assayed on ABTS (88%; IC50 = 3.89 µg mL−1) or DPPH (90%; IC50 = 2.06 µg mL−1), which was even
higher than that of the BHT positive control, however showed medium (56%) or low (30%) antioxidant
activity when assayed on FRP or CCA, respectively. Acetone extracts from H. salinarum HM2, on the
other hand, exhibited a high antioxidant activity when assayed with DPPH (66%; IC50 = 8.90 µg mL-1)
and only low (20–30%) or medium (50%) activity when tested on the other antioxidant assays,
showing that differences can be observed between the same type of fractions obtained from both
tested haloarchaea.
In addition, the aqueous extracts, obtained from the acetone precipitate of H. hispanica HM1,
exhibited higher antioxidant activity in FRP assay (82%; EC50 = 3.12 µg mL−1) than the same extract
from H. salinarum HM2 (75%; EC50 = 3.59 µg/mL). These results suggest that H. hispanica HM1 extracts
possess a higher antioxidant potential than the H. salinarum HM2 ones.
The results obtained entail a complete study about the antioxidant capacity of haloarchaea, as a
wide range of antioxidant assays have been employed. In agreement with the results obtained for the
new two strains isolated, H. hispanica HM1 and H. salinarum HM2, extracts from several haloarchaeal
species have been reported to show antioxidant activity in the DPPH assay, which is the test most
commonly used for this purpose. Examples of this are Halogeometricum rufum, Halogeometricum limi,
Haladaptatus litoreus, Haloplanus vescus, Halopelagius inordinatus, Halogranum rubrum, and Haloferax
volcanii, whose IC50 values varied from 2.5 to 10 µg mL−1 [12] and Haloterrigena turkmenica with an IC50
of 4.49 µg mL−1 [57]. Regarding the aqueous protein-rich extracts, there are no available reports for
comparison in the case of haloarchaea. The fact that different extracts from the studied archaea showed
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antioxidant activity makes us think that haloarchaea could have antioxidant compounds of different
nature and polarity, present in different fractions. Polyphenolic compounds are usually related to the
antioxidant activity of plants and algal extracts, [58–60]; however there is no evidence to the date of
their production in haloarchaea, which antioxidant potential is mainly attributed to the presence of
carotenoid pigments. Finally, moderate levels of copper ions chelating activity was found in extracts
from both strains. This activity has been previously reported in saline microalgae [61], but has not been
studied in haloarchaeal members as yet. Taken together, those results indicate that haloarchaeal extracts
could be a promising source of antioxidant compounds with widespread applications as natural food
preservatives, colorants and supplements [62], as well as sources of leads for pharmaceutical and
cosmetic formulations to prevent oxidative damage [63].
3.2.2. In Vitro Neuroprotective, Antidiabetic, Melanogenic, and Anti-Inflammatory Properties of the
Haloarchaeal Extracts
All the extracts were tested to determine their potential activity over the enzymes tyrosinase
(TYRO), α-glucosidase, α-amylase, cyclooxygenase 2 (COX-2) and acetylcholinesterase (AChE), which
are classical targets in the search for new drug leads for the treatment of diverse dermatological,
metabolic, inflammatory, and neurological diseases.
Among all the tested enzymes, the highest percentage of activity inhibition was observed for
COX-2, specifically in the acetone fraction of both haloarchaea, being the H. hispanica HM1 extracts
more active, with a 65% of enzyme inhibition, than the same extracts of H. salinarum HM2, with 47% of
COX-2 inhibition. Also, a slight inhibition of COX-2, around 15%, was found in the aqueous fractions
of H. salinarum HM2 (Figure 3). COX is the central enzyme in the biosynthetic pathway of prostanoids,
which are important biological mediators as prostaglandins, prostacyclin, and thromboxane. There are
two known isoenzymes: COX-1 and COX-2. COX-1 is constitutively expressed in many tissues and is
the predominant form in gastric mucosa and in kidney, while COX-2 is not expressed under normal
conditions in most cells, but elevated levels are found during inflammation. Coxibs include a variety of
powerful drugs, whose primary mechanism is the potent inhibition of the COX-2 enzyme. These drugs
are used worldwide to treat diverse medical conditions as muscular skeletal pain and inflammation.
Unfortunately, their use is limited due to negative effects on renal clearance and increased risk of
cardiovascular pathology [64]. Therefore, there is a clear need to develop new COX-2 inhibitors free of
the aforementioned problems, which can provide pain and inflammatory relief.
Regarding the antidiabetic potential, the aqueous and acetone extracts obtained from H. hispanica
HM1 biomass exhibited inhibitory activities of 33 and 36%, respectively, on α-amylase activity. In the
same way, glucosidase inhibition of 36% was achieved with the aqueous protein-rich extract of
H. salinarum HM2. Both carbohydrate-hydrolyzing enzymes, α-glucosidase and α-amylase, have
been proposed as targets to control the hyperglycemia associated with diabetes mellitus type 2 [65].
The inhibitory potential of these extracts was lower than that of the reference antidiabetic acarbose,
which was about 65% for α-amylase and 80% for α-glucosidase (Figure 3).
With respect to the neuroprotective assay, acetone extracts obtained from the biomass of
both archaea and all the extracts recovered from culture media showed the capacity of inhibiting
acetylcholinesterase activity in a range from 20 to 37%, which was lower than the AChE inhibitory
potential of the positive control, galantamine (78%). Conversely, aqueous extracts from both
strains exhibited the antagonist activity; they were able to induce the activity of the enzyme by
45%–49% (Figure 3). Acetylcholinesterase catalyzes the hydrolysis of cholinergic neurotransmitters
such as acetylcholine and others choline esters to terminate the synaptic transmission rapidly.
The reversible inhibition of this enzyme is being explored as treatment for Alzheimer’s disease [66],
while acetylcholinesterase activation is required in cholinergic crisis related to acetylcholine
accumulations [67].
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Figure 3. In vitro activity of haloarchaeal extracts on enzy es related to diabetic, neurodegenerative
skin pig entation, and infla atory diseases. Percentages of inhibition of the enzy es: α-amylase,
α-glucosidase, acetylcholinesterase (AChE), tyrosinase (TYRO) and cyclooxygenase 2 (COX-2) by the
all extracts obtained in different solvents (hexane, dichloromethane, ethyl acetate, chloroform, aqueous
buffer and acetone) from H. hispanica HM1 (A) and H. salinarum HM2 (B) strains are represented.
A known inhibitor for each enzyme was included as control. For each assay, the data were submitted to
one-way variance analysis (ANOVA). Bars are followed by different superscript letters (a–f), which
denote groups with significant differences according to the Duncan’s Multiple Range Test (p < 0.05).
Regarding tyrosinase activity, none of the extracts studied showed a significant ability to inactivate
this oxidase involved in the synthesis of melanin. However, it is remarkable that the acetone extracts
from both strains exhibited, in our experimental conditions, a high percentage of tyrosinase activation
(73–78%). Although inhibitors of tyrosinase are used to alleviate skin hyperpigmentation and prevent
age spots [68], inducers of this enzyme can stimulate melanogenesis and contribute to treat skin
depigmentation disorders, such as vitiligo [69,70]. Many melanogenesis stimulators have been isolated
from natural sources, but to our knowledge, this is the first report about the influence of archaeal
extracts on tyrosinase activity. High repigmentation ratios of vitiligo patients treated with Dead Sea
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Climatotherapy, which includes sea baths, have been reported [71]. The mineral composition of these
saline waters seems to have positive effects in this and other skin conditions; however, the possible
therapeutic role of the haloarchaea, which are usual inhabitants of hypersaline water, has not been
investigated yet [72]. Furthermore, Vitiligo has also been found to be related to oxidative stress and to
the activation/deactivation of acetylcholinesterase [73], and we have demonstrated that haloarchaeal
extracts show antioxidant activity and the ability to induce acetylcholinesterase in vitro.
In this study, we have demonstrated that haloarchaeal extracts have interesting bioactive properties.
Their ability to inhibit the COX-2 enzyme is especially remarkable, and although in vitro antidiabetic
properties of the studied extracts were low, their ability to induce acetylcholinesterase and tyrosinase
are noteworthy. To our knowledge, these results represent the first report on the potential applicability
of haloarchaeal extracts as a potential source of compounds for the treatment of the aforementioned
diseases. To date, the applicability of haloarchaea has been mainly focused on their carotenoids, which
have been described as antiproliferative [20] and erythroprotective agents [12], and enhancers of sperm
cells viability [13].
3.3. Antimicrobial Activity and MIC Determination
The antimicrobial activity of the different extracts obtained from the two new haloarchaeal strains
was assayed against a collection of typical fish and human pathogenic bacteria, against representative
microalgae and yeast species and over other haloarchaea typically found in hypersaline environments,
by using the agar diffusion method.
This screening revealed that only the acetone extracts showed considerable antimicrobial activity.
Acetone extracts from the two tested haloarchaeal strains, H. hispanica HM1 and H. salinarum HM2,
showed to be active against bacteria, microalgae, and archaea, but not on yeasts. Zones of inhibition,
with diameters which varied according to the susceptibility of the target microorganism from 0.5 to 6
cm, were used as indicators of antimicrobial activity (Figure 4). Both acetone extracts inhibited the
growth of all the human pathogenic bacteria assayed and of most fish pathogenic bacteria studied, with
inhibition halos ranging from 0.5 to 2 cm. In addition, both extracts exhibited important antimicrobial
activity against microalgae, which was especially pronounced over halophilic microalgae from the
Dunaliella genus, with inhibition halos sized from 2 to 6 cm. Moreover, high activity was found against
all the tested extreme halophilic archaea and bacteria, with inhibition zones from 0.5 to 4 cm (Table 1).
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Table 1. Antimicrobial activity of acetone extracts. 
 Target Microorganisms 
Acetone Extract 
H. hispanica 
HM1 
H. salinarum 
HM2 
Human pathogenic 
bacteria 
Bacillus cereus + + 
Escherichia coli + − 
Micrococcus luteus + ++ 
Staphylococcus aureus + + 
Marine fish pathogenic 
bacteria 
Aeromonas salmonicida CECT 894T − − 
Edwardsiella tarda CECT 849T − − 
Lactococcus garvieae CECT 4531T − − 
Nocardia seriolae DSM 44129T − − 
Figure 4. Antimicrobial activity of ac ts. Antimicrobial activity was indicated by zones of
inhib tion of growth or halos. aki t the diameter of the halo, the susceptibility of the
differ nt micro rganisms to the extract l ifi i four reference groups: (A) 0.5–1 cm (+) in
Bacillus cereus; (B) 1–2 c ( ) in Staphylococcus aureus; (C) 2–4 cm (+++) i Dunaliella bardawil and
(D) 4–6 cm ( ++) in Dunaliella salina.
Several dilutions of aceton extracts c ntaining pigment concentrations of 100, 80, 40, 20, 10,
5 and 1 µg mL−1 were prepared to detect their MIC on different target microorganisms. For this
purpose, one of the most susceptible microorganisms of each group was selected; Micrococcus luteus for
human pathogenic bacteria, Vibrio harveyi for fish pathogenic bacteria, Halogeometricum for archaea,
and Dunaliella salina for microalgae. The obtained results revealed that the extracts were more active
against halophilic microorganisms, with MIC values of 10 µg mL−1 for D. salina and 5 µg mL−1
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for Halogeometricum (Figure 5); while for the bacteria species M. luteus and V. harveyi, MIC values
were 100 µg mL−1.
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Figure 5. Minimal Inhibitory Concentration plate assay. Dilutions of the active extracts were assayed
against one of the most susceptible microorganisms of each group. Halophilic microorganisms,
represented by Dunaliella salina and Halogeometricum, showed to be more sensitive to the extracts.
Lipophilic extracts and pigments of diverse origin have shown antimicrobial activity against
pathogenic human bacteria and fungi. In this sense, several studies have been carried out with positive
results with pigments derived from plants and vegetables [59,74]; from algae [75,76] and from saline
and halophilic bacteria [21,23,77], but to date the reports about the applicability of such extracts as
antimicrobial agents are scarce. Recent studies report a moderate inhibitory effect of the extracts from
the haloarchaea Halorubrum sp. on pathogenic bacteria, with inhibition halos up to 15 mm [24], which is
quite lower than the results obtained is this work. Most studies about antimicrobial interactions
between halophilic bacteria and archaea are focused on halocins [78–80]. Therefore, the present research
entails a pioneer report on the effectiveness of haloarchaeal acetonic extracts against a wide range of
different microorganisms belonging to the three domains of life. Likewise, this study represents the
first outcome from the use of Haloarcula and Halobacterium as source of antimicrobial compounds.
4. Conclusions
This research explores the antioxidant, antimicrobial and other bioactive properties of the extracts
obtained from two new isolated haloarchaea strains and confirms that they can be an exceptional
source of new bioactive extracts, able to modulate the activity of several medically relevant enzymes,
and with potential applicability in pharmacy and cosmetics. The acetone fractions, showed to be the
most active extracts in most of the assays, being their antioxidant, antimicrobial, and anti-inflammatory
potential especially remarkable. Moreover, acetone extracts from the two haloarchaea have shown
for the first time to have the ability to activate the melanogenic enzyme tyrosinase and to inhibit
the enzyme cyclooxygenase-2 (COX-2), implicated in the inflammatory response; while the aqueous
extracts from both strains have demonstrated to enhance in vitro the acetylcholinesterase activity;
this enzyme catalyzes the hydrolysis of cholinergic neurotransmitters and has been reported to be
involved in neurological disorders and to have a role in apoptosis. In this study, we have untapped
novel unexplored bioactivities of haloarchaea, which can be the source of potential new therapeutic
compounds. However, many archaea species are still undiscovered, many potential bioactivities
remain to be studied, and the isolation and identification of the compounds responsible for these
activities is still a pending issue. Further work will be carried out to fully characterize the composition
of the active extracts and their efficacy in in vivo assays.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-7737/9/9/298/s1,
Figure S1: Sequences of the 16S rRNA genes amplified from the new haloarchaea.
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